Joe Biden signs bill on COVID origins declassification

President Joe Biden signed a bipartisan bill Monday that directs the federal government to declassify as much intelligence as possible about the origins of COVID-19 more than three years after the start of the pandemic. The legislation, which passed both the House and Senate without dissent, directs the Office of the Director of National Intelligence to declassify intelligence related to China’s Wuhan Institute of Virology. It cites “potential links” between the research that was done there and the outbreak of COVID-19, which the World Health Organization declared a pandemic on March 11, 2020. The law allows for redactions to protect sensitive sources and methods. U.S. intelligence agencies are divided over whether a lab leak or a spillover from animals is the likely source of the deadly virus. Experts say the true origin of the coronavirus pandemic, which has killed more than 1.1 million in the U.S. and millions more around the globe, may not be known for many years — if ever. Biden, in a statement, said he was pleased to sign the legislation. “My Administration will continue to review all classified information relating to COVID–19’s origins, including potential links to the Wuhan Institute of Virology,” he said. “In implementing this legislation, my Administration will declassify and share as much of that information as possible, consistent with my constitutional authority to protect against the disclosure of information that would harm national security.” Republished with the permission of The Associated Press.
Anthony Fauci to retire in December; Jerry Carl critical of the USA’s top doctor

On Monday, Dr. Anthony Fauci announced that he will step down from his role as the director of the National Institute of Allergy and Infectious Diseases (NIAID) and the Chief Medical Advisor to the President in December. Fauci served various Presidents over decades, but COVID-19 and the U.S. response to the global pandemic vaulted Fauci into being one of the most controversial men in America. Congressman Jerry Carl has long been a critic of Dr. Fauci. “Fauci just announced he’s resigning. It’s about dang time!” Rep. Carl said on Twitter. “I called for his immediate removal last summer, and I’ve also introduced a bill to strip him of his pension since he LIED to the American people. We will hold him accountable.” “After more than 50 years of government service, I plan to pursue the next phase of my career while I still have so much energy and passion for my field,” Fauci said in a statement. “I want to use what I have learned as NIAID Director to continue to advance science and public health and to inspire and mentor the next generation of scientific leaders as they help prepare the world to face future infectious disease threats.” U.S. Sen. Rand Paul (R-Kentucky) has also been a harsh critic of Dr. Fauci and his handling of the COVID-19 global pandemic. “Fauci’s resignation will not prevent a full-throated investigation into the origins of the pandemic,” Sen. Paul said on social media. “He will be asked to testify under oath regarding any discussions he participated in concerning the lab leak.” Fauci first went to work at the NIH in 1968. Paul and some experts believe that the source of the SARS-CoV-2 strain of the coronavirus that causes COVID-19 escaped from a lab studying variations of the coronavirus. This lab received some funding from the NIH. Fauci denies the conjecture that the virus escaped from a lab. President Joseph Biden praised Fauci in a statement. “Dr. Fauci has served under seven Republican and Democratic Presidents during his career, beginning with Ronald Reagan,” Biden wrote. He was awarded the Presidential Medal of Freedom in 2008 under President George W. Bush. For almost four decades, he has served as Director of the National Institute of Allergy and Infectious Diseases, helping our country navigate health crises ranging from HIV/AIDS to COVID-19. Because of Dr. Fauci’s many contributions to public health, lives here in the United States and around the world have been saved. As he leaves his position in the U.S. Government, I know the American people and the entire world will continue to benefit from Dr. Fauci’s expertise in whatever he does next. Whether you’ve met him personally or not, he has touched all Americans’ lives with his work. I extend my deepest thanks for his public service. The United States of America is stronger, more resilient, and healthier because of him.” Jerry Carl represents Alabama’s First Congressional District. To connect with the author of this story, or to comment, email brandonmreporter@gmail.com.
White House urges caution on COVID variants, pushes boosters

The Biden administration is calling on people to exercise renewed caution about COVID-19, emphasizing the importance of getting booster shots for those who are eligible and wearing masks indoors as two new highly transmissible variants are spreading rapidly across the country. The new variants, labeled BA.4 and BA.5, are offshoots of the omicron strain that has been responsible for nearly all of the virus spread in the U.S. and are even more contagious than their predecessors. White House doctors stressed the importance of getting booster doses, even if you have recently been infected. “Currently, many Americans are under-vaccinated, meaning they are not up to date on their COVID-19 vaccines,” said Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention. “Staying up to date on your COVID-19 vaccines provides the best protection against severe outcomes.” Walensky said the U.S. has seen a doubling in the number of hospitalizations due to COVID-19 since April, reflecting the spread of the new subvariants, though deaths remain steady around 300 per day. Dr. Anthony Fauci, the nation’s top infectious disease expert, said while the new variants are concerning, with boosters, indoor masking, and treatments the country has the tools to keep them from being disruptive. “We should not let it disrupt our lives,” he said, “but we cannot deny that it is a reality that we need to deal with.” He added that even if someone recently had COVID-19, they should get a booster. “Immunity wanes, so it is critical to stay up to date with COVID-19 vaccines,” he said. All Americans age five and over should get a booster five months after their initial primary series, according to the CDC, and those age 50 and over — or those who are immunocompromised — should get a second booster four months after their first. According to CDC, tens of millions of eligible Americans haven’t received their first booster, and of those over 50 who got their first booster, only 28% have received their second. “If you’re over 50 and you haven’t gotten the shot this year, you should go get a shot,” said White House COVID-19 coordinator Dr. Ashish Jha. “It’s going to save your life.” Jha and Fauci said the U.S. is regularly discussing expanding eligibility for a second booster shot to all adults but that no decision has been made yet. “It’s a regulatory decision on the part of the FDA,” Fauci said. Jha said people who are eligible for a booster but haven’t received one shouldn’t wait for forthcoming vaccines targeted at the omicron strain in addition to the original form of the coronavirus. The U.S. has ordered 105 million of those updated shots, which studies show provide better protection against omicron variants, but they won’t be available until the fall. “Let me be clear, if you get vaccinated today, you’re not going to be ineligible to get the variants specific vaccine, as we get into the later part of fall and winter,” Jha said. “So, this is not a tradeoff. We’ve got plenty. It’s a great way to protect yourself.” Added Fauci, “The threat to you is now.” Walensky noted that CDC data shows that about a third of Americans are living in areas the agency classifies as experiencing a high level of COVID spread, where the agency recommends people wear masks in public indoor spaces. Another 41% live in the CDC’s “medium” level, where it recommends that people consider their own individual risk and consider masking. Republished with the permission of The Associated Press.
COVID coverage for all dries up even as hospital costs rise

For the first time, the U.S. came close to providing health care for all during the coronavirus pandemic — but for just one condition, COVID-19. Now, things are reverting to the way they were as federal money for COVID care of the uninsured dries up, creating a potential barrier to timely access. But the virus is not contained, even if it’s better controlled. And safety-net hospitals and clinics are seeing sharply higher costs for salaries and other basic operating expenses. They fear they won’t be prepared if there’s another surge and no backstop. “We haven’t turned anybody away yet,” said Dr. Mark Loafman, chair of family and community medicine at Cook County Health in Chicago. “But I think it’s just a matter of time … People don’t get cancer treatment or blood pressure treatment every day in America because they can’t afford it.” A $20 billion government COVID program covered testing, treatment, and vaccine costs for uninsured people. But that’s been shut down. Special Medicaid COVID coverage for the uninsured in more than a dozen states also likely faces its last months. At Parkland Health, the frontline hospital system for Dallas, Dr. Fred Cerise questions the logic of dialing back federal dollars at a time when health officials have rolled out a new “test-to-treat” strategy. People with COVID-19 can now get antiviral pills to take at home, hopefully avoiding hospitalization. Vice President Kamala Harris, who recently tested positive but is back working at the White House, is an example. “Test-to-treat will be very difficult for uninsured individuals,” predicted Cerise, president and CEO of the system. “If it’s a change in strategy on the large scale, and it’s coming without funding, people are going to be reluctant to adopt that.” Officials at the federal Department of Health and Human Services say the new antiviral drugs like Paxlovid have been paid for by taxpayers, and are supposed to be free of charge to patients, even uninsured ones. But they acknowledge that some uninsured people can’t afford the medical consultation needed to get a prescription. “We hear from state and local partners that the lack of funding for the Uninsured Program is creating challenges for individuals to access medications,” said Dr. Meg Sullivan, chief medical officer for the HHS preparedness and response division. The nation has not pinched pennies on the pandemic before. “We’re well short of universal health coverage in the U.S., but for a time, we had universal coverage for COVID,” said Larry Levitt, a health policy expert with the nonpartisan Kaiser Family Foundation. “It was extraordinary.” Recently an urgent White House request for $22.5 billion for COVID priorities failed to advance in Congress. Even a pared-back version is stuck. Part of the Biden administration’s request involves $1.5 billion to replenish the Uninsured Program, which paid for testing, treatment, and vaccine-related bills for uninsured patients. The program has now stopped accepting claims due to lack of money. That program, along with a less known Medicaid option for states, allowed thousands of uninsured people to get care without worrying about costs. Bipartisan support has given way as congressional Republicans raise questions about pandemic spending. The Uninsured Program was run by the Health Resources and Services Administration, an HHS agency. Medical providers seeing uninsured people could submit their bills for reimbursement. Over the last two years, more than 50,000 hospitals, clinics, and medical practices received payments. Officials say they can turn the program back on if Congress releases more money. The Medicaid coverage option began under the Trump administration as a way to help states pay for testing uninsured people. President Joe Biden’s coronavirus relief bill expanded it to treatment and vaccine costs as well. It’s like a limited insurance policy for COVID. The coverage can’t be used for other services, like a knee replacement. The federal government pays 100% of the cost. Fifteen states, from deep blue California to bright red South Carolina, have taken advantage of the option, along with three U.S. territories. It will end once the federal coronavirus public health emergency is over, currently forecast for later this year. New Hampshire Medicaid Director Henry Lipman said the coverage option allowed his state to sign up about 9,500 people for COVID care that includes the new antiviral drugs that can be taken at home. “It’s really the safety net for people who don’t have any access to insurance,” said Lipman. “It’s a limited situation, but in the pandemic, it’s a good back-up to have. It makes a lot of sense with such a communicable disease.” With COVID cases now at relatively low levels, demand for testing, treatment, and vaccination is down. But the urgency felt by hospitals and other medical service providers is driven by their own bottom lines. In Missouri, Golden Valley Memorial Healthcare CEO Craig Thompson is worried to see federal funding evaporate just as operating costs are soaring. Staff have gotten raises, drug costs have risen by 20%, and supply costs by 12%. “We’ve now exited this pandemic … into probably the highest inflationary environment that I’ve seen in my career,” Thompson said. The health system serves a largely rural area between Kansas City and Springfield. In Kentucky, Family Health Centers of Louisville closed a testing service for uninsured people once federal funds dried up. The private company they were working with planned to charge $65 a test. Things are manageable now because there’s little demand, said spokeswoman Melissa Mather, “but if we get hit with another omicron, it’s going to be very difficult.” Floridian Debra McCoskey-Reisert is uninsured and lost her older brother to COVID-19 in the first wave two years ago. In one of their last conversations, he made her promise she wouldn’t catch the virus. McCoskey-Reisert, who lives north of Tampa, has managed to avoid getting sick so far. But she’s overshadowed by fear of what could happen if she or her husband get infected. “If either one of us get sick with COVID, we don’t have a way to pay for it,” she said. “It would
Survey shows continued apprehension among rural residents regarding COVID-19 vaccinations

A survey by a rural health organization regarding COVID-19 vaccines shows apprehension by many about getting the shot. The National Rural Health Organization, with locations in Illinois, paired with the U.S. Centers for Disease Control and Prevention to find out how adults, parents and teens in rural areas feel about getting vaccinated. Only 15% of rural adults and 14% of teens believe vaccines are good protection from diseases. Nearly 40% of rural teens said they are concerned the vaccines may result in serious side effects, which Amy Elizondo, chief strategy officer with the NRHA, said is very revealing. “We wanted to get perspective within these groups that we haven’t readily heard from, in particular rural teenagers, the first time they have been surveyed in this particular topic area,” Elizondo said. Vaccination rates in many rural areas of Illinois lag behind urban areas, as many southern counties are reporting full vaccination rates lower than 40%, including in Alexander County, where less than a fourth of the population is fully vaccinated. Thirty percent of adults surveyed said the information they receive about vaccines is reliable and trustworthy, but many were not so sure. “When looking at barriers to vaccination, folks reported feeling overwhelmed by the information and misinformation,” Elizondo said. Health care providers are the most trusted source for COVID-19 vaccine information across all three rural samples (71%+ say they trust their health care provider “a lot” or “some” when receiving COVID-19 vaccine advice or information) of the options tested. When asked about their current level of concern about COVID-19 in general, 31% of rural adults said they were very concerned, while only 12% of teens reported the same. This poll was conducted between Feb. 1 and Feb. 22 among a sample of 1,806 rural adults, 475 rural parents, and 220 rural teens. Republished with the permission of The Center Square.
Kay Ivey awards $10 million in Covid-19 grants for emergency services providers

On Wednesday, Gov. Kay Ivey announced $10 million of the State Fiscal Recovery Fund from the American Rescue Plan Act (ARPA) has been awarded to establish COVID recovery grants for emergency services providers. The program aims to provide support to Alabama’s emergency services providers that have been financially impacted by the COVID-19 pandemic. Eligible applicants for this grant program are volunteer rescue squads, E-911 Boards, and emergency services providers that are not an agency or department of a city, county, state, or federal government. Alabama will offer grants up to $10,320 for providers that meet eligibility requirements. The application period for the Alabama Emergency Services Provider Grant Program will be open from noon April 27 through noon May 13, 2022. “Alabama’s emergency service providers greatly supported our communities throughout the pandemic, often times putting their own lives on the line to provide rapid care. Now, we are in a position to return the favor and help them in their recovery efforts,” stated Governor Ivey. “I appreciate the Alabama Legislature for their partnership in making this critical funding available to our emergency service providers, and I encourage them to apply and utilize these funds to further invest in public safety services.” Alabama received $2.1 billion in ARPA funds. The Alabama Legislature appropriated $136,796,346 of that to Alabama’s State Fiscal Recovery Revenue Replacement Fund with $10 million of these funds to be distributed to Alabama’s emergency services providers.
Kamala Harris positive for COVID-19, Joe Biden not a ‘close contact’

Vice President Kamala Harris tested positive for COVID-19 on Tuesday, the White House announced, underscoring the persistence of the highly contagious virus even as the U.S. eases restrictions in a bid to return to pre-pandemic normalcy. Neither President Joe Biden nor first lady Jill Biden was considered a “close contact” of Harris in recent days, said the vice president’s press secretary, Kirsten Allen. Harris had been scheduled to attend Biden’s Tuesday morning Presidential Daily Brief but was not present, the White House said. She had returned Monday from a weeklong trip to the West Coast. The last time she saw Biden was the previous Monday, April 18. “I have no symptoms, and I will continue to isolate and follow CDC guidelines,” Harris tweeted. “I’m grateful to be both vaccinated and boosted.” Biden phoned her Tuesday afternoon to make sure she “has everything she needs” while working from home, the White House said. Harris, 57, received her first dose of the Moderna COVID-19 vaccine weeks before taking office and a second dose just days after Inauguration Day in 2021. She received a booster shot in late October and an additional booster on April 1. Fully vaccinated and boosted people have a high degree of protection against serious illness and death from COVID-19, particularly from the most common and highly transmissible omicron variant. Harris’ diagnosis comes a month after her husband, Doug Emhoff, recovered from the virus, as a wave of cases of the highly transmissible omicron subvariant has spread through Washington’s political class, infecting Cabinet members, White House staffers, and lawmakers, including House Speaker Nancy Pelosi. Sens. Ron Wyden, D-Ore., and Chris Murphy, D-Conn., tested positive on Tuesday. Allen said Harris would follow Centers for Disease Control and Prevention guidelines “and the advice of her physicians.” It was not immediately clear whether she is being prescribed any antiviral treatments. The White House has put in place strict COVID-19 protocols around the president, vice president, and their spouses, including daily testing for those expected to be in close contact with them. Biden is tested regularly on the advice of his physician, the White House has said and last tested negative on Monday. “We have a very, very contagious variant out there,” said White House COVID-19 coordinator Dr. Aashish Jha on Tuesday. “It is going to be hard to ensure that no one gets COVID in America. That’s not even a policy goal.” He said the administration’s goal is to make sure people don’t get seriously ill. Jha added that despite the precautions, it is possible that Biden himself will come down with the virus at some point. “I wouldn’t say it’s just a matter of time, but of course, it is possible that the president, like any other American, could get COVID,” he said. “There is no 100% anything.” Psaki said she “would not expect” any changes to White House protocols. After more than two years and nearly a million deaths in the U.S., the virus is still killing more than 300 people a day in the U.S., according to the CDC. The unvaccinated are at far greater risk, more than twice as likely to test positive and nine times as likely to die from the virus as those who have received at least a primary dose of the vaccines, according to the public health agency. Harris’ diagnosis comes as the Biden administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid, reassuring doctors that there is ample supply for people at high risk of severe illness or death from the virus. Paxlovid, when administered within five days of symptoms appearing, has been proven to bring about a 90% reduction in hospitalizations and deaths among patients most likely to get severe disease. In addition to her husband’s diagnosis, Harris was identified as a “close contact” after her communications director tested positive on April 6. The Centers for Disease Control and Prevention defines “close contact” with an infected person as spending 15 minutes or more with them over a 24-hour period. The CDC says people with “close contact” do not need to quarantine if they are up to date on their vaccines but should wear well-fitting masks around other people for 10 days after the contact. Republished with the permission of the Associated Press.
Feds will appeal mask ruling only if mandate still needed

The Justice Department said Tuesday it will not appeal a federal district judge’s ruling that ended the nation’s federal mask mandate on public transit unless the Centers for Disease Control and Prevention believes the requirement is still necessary. In a statement released a day after a Florida judge ended the sweeping mandate, which required face coverings on planes and trains and in transit hubs, Justice Department spokesman Anthony Coley said officials believe that the federal mask order was “a valid exercise of the authority Congress has given CDC to protect the public health.” He said it was “an important authority the Department will continue to work to preserve.” Coley said the CDC had said it would continue to assess public health conditions, and if the agency determined a mandate was necessary for public health, the Justice Department would file an appeal. The Justice Department said Tuesday it will not appeal a federal district judge’s ruling that ended the nation’s federal mask mandate on public transit unless the Centers for Disease Control and Prevention believes the requirement is still necessary. THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below. A pilot declared over the loudspeaker on a cross-country Delta Air Lines flight that passengers were no longer required to wear masks, eliciting cheers from the cabin and prompting some on board to immediately toss their face coverings onto their seats. “Feel free to burn them at will,” a train conductor told New Jersey commuters Tuesday. Other passengers were confused, startled, and angered by the abrupt change, however, especially those who booked trips in the belief that their unvaccinated children would be traveling in a masked environment. A federal judge’s decision Monday to throw out a mask requirement on public transportation did away with the last major vestige of federal pandemic rules and led to a mishmash of new locally created rules that reflected the nation’s ongoing division over how to battle the virus. Major airlines and airports in places like Dallas, Atlanta, Los Angeles, and Salt Lake City quickly switched to a mask-optional policy. New York City, Chicago, Los Angeles, and Connecticut continued to require them on mass transit. But a host of other cities ditched their mandates, even though the Centers for Disease Control and Prevention continued to recommend masking on transportation. Brooke Tansley, a television producer and former Broadway performer, boarded a flight with her 4-year-old and 8-month-old baby— neither old enough to be vaccinated — only to learn the mask mandate had ended mid-flight. “Very very angry about this,” she said in a tweet, noting that her baby was too young to wear a mask. For many, though, the news was welcome. A video showed some passengers on a Delta Air Lines flight cheering and applauding as they took off their masks upon hearing the announcement they were now optional. One man could be seen happily twirling his mask on his finger. On a Southwest Airlines flight Monday from Detroit to Nashville, the change to optional status was incorporated into the safety announcements, prompting murmurs and fist pumps from some passengers and no audible complaints. At the Seattle airport, Deb McLane continued to wear a mask because of the crowds but said she was “thankful that it’s not being forced on us anymore.” In Portland, Oregon, transit employees were immediately working on taking down “mask required” announcements and signs, but said it would likely take several days to remove everything. The city joined Atlanta, Boston, Philadelphia, Washington, D.C., Kansas City, Missouri, and two of Alaska’s largest cities, Anchorage and Juneau, in making masking optional on mass transit. “We know our riders have mixed feelings about the mandate ending,” Portland’s public transit agency, TriMet, posted on social media. “We ask everyone to be respectful of others as we all adjust to this change.” Some passengers at Chicago’s Union Station said the rules were confusing. Both Amtrak and Metra, the regional commuter rail service, said masks still are required, but some passengers walking through the station didn’t wear them. “It’s like this patchwork of different rules and enforcement of it,” said Erik Abderhalden, who wore a mask as he waited for a Metra train to his home in suburban Naperville. “I mean, it’s like Swiss cheese … there’s no uniformity and it seems pretty laissez-faire.” The Chicago Transit Authority also said it still will require masks on city trains and buses, for now. Subway rider Cooper Klinges was pleased that New York City’s public transit system wasn’t following the trend and planned to keep its mask requirement in place. As he waited at a train station in Brooklyn, New York, he said he canceled a flight earlier this year over concerns about the virus. “I don’t think we are out of the woods yet,” said Klinges, a teacher, citing concerns about the BA.2 omicron subvariant of the coronavirus. “It is still around. We have to still stick it out.” The ride-sharing companies Lyft and Uber announced on their websites Tuesday that masks will now be optional while riding or driving. The national mask rule for travelers was one of the last of the pandemic restrictions still in place. It sparked online flame throwing between those who felt they were crucial to protecting people and those who saw it as an unnecessary inconvenience or even government overkill. Some flight attendants found themselves cursed and even attacked by passengers who refused to comply. In a 59-page lawsuit ruling, U.S. District Judge Kathryn Kimball Mizelle in Tampa said the U.S. Centers for Disease Control and Prevention overstepped its authority in issuing the original health order on which the TSA directive was based. She also said the order was fatally flawed because the CDC didn’t follow proper rulemaking procedures. The Justice Department declined to comment when asked if it would seek an emergency stay to block the judge’s order. While airline and mass transit passengers around the country were ditching masks, the White House made clear that those traveling with President Joe Biden
Florida judge voids U.S. mask mandate for planes, other travel

A federal judge in Florida struck down the national mask mandate covering airlines and other public transportation Monday, and the Biden administration said the rule would not be enforced while federal agencies decide how to respond to the judge’s order. The ruling appeared to free operators to make their own decisions about mask requirements, with several airlines announcing they would drop mandates but New York City’s public transit system planning to keep one in place. The Association of Flight Attendants, the nation’s largest union of cabin crews, has recently taken a neutral position on the mask rule because its members are divided about the issue. On Monday, the union’s president appealed for calm on planes and in airports. “The last thing we need for workers on the frontlines or passengers traveling today is confusion and chaos,” union leader Sara Nelson said. Nelson said it takes airlines 24 to 48 hours to put new procedures in place and tell employees about them. She said passengers should check with airlines for updates about travel requirements. The decision by U.S. District Judge Kathryn Kimball Mizelle in Tampa, an appointee of former President Donald Trump, also said the U.S. Centers for Disease Control and Prevention failed to justify its decision and did not follow proper rulemaking procedures that left it fatally flawed. In her 59-page ruling, Mizelle said the only remedy was to vacate the rule entirely across the country because it would be impossible to end it for the limited group of people who objected in the lawsuit. The judge said “a limited remedy would be no remedy at all” and courts have full authority to make a decision such as this — even if the CDC’s goals in fighting the virus are laudable. The Justice Department declined to comment when asked if it would seek an emergency stay to block the judge’s order. The CDC also declined to comment. The White House said the court ruling means that for now the mask order “is not in effect at this time.” “This is obviously a disappointing decision,” White House press secretary Jen Psaki told reporters. “The CDC is recommending wearing a mask on public transit.” The CDC had recently extended the mask mandate, which was set to expire Monday, until May 3 to allow more time to study the BA.2 omicron subvariant of the coronavirus now responsible for the vast majority of cases in the U.S. In New York, Metropolitan Transportation Authority communications director Tim Minton said the system was “continuing to follow CDC guidelines and will review the Florida court order.” The MTA operates New York City buses and subway trains as well as two commuter rail lines. Face coverings have been mandatory on all trains and buses since early in the pandemic. United Airlines said in a statement that, effective immediately, masks would no longer be required on domestic flights or certain international flights. “While this means that our employees are no longer required to wear a mask – and no longer have to enforce a mask requirement for most of the flying public – they will be able to wear masks if they choose to do so, as the CDC continues to strongly recommend wearing a mask on public transit,” United said. The federal mask requirement for travelers was the target of months of lobbying from the airlines, which sought to kill it. The carriers argued that effective air filters on modern planes make transmission of the virus during a flight highly unlikely. Republicans in Congress also fought to kill the mandate. Critics have seized on the fact that states have rolled back rules requiring masks in restaurants, stores, and other indoor settings, and yet COVID-19 cases have fallen sharply since the omicron variant peaked in mid-January. There have been a series of violent incidents on aircraft that have mainly been attributed to disputes over the mask-wearing requirements. The lawsuit was filed in July 2021 by two plaintiffs and the Health Freedom Defense Fund, described in the judge’s order as a nonprofit group that “opposes laws and regulations that force individuals to submit to the administration of medical products, procedures, and devices against their will.” Republican Florida Gov. Ron DeSantis, who was not directly involved in the case but has battled against many government coronavirus requirements, praised the ruling in a statement on Twitter. “Great to see a federal judge in Florida follow the law and reject the Biden transportation mask mandate. Both airline employees and passengers deserve to have this misery end,” DeSantis tweeted. Republished with the permission of the Associated Press.
FDA authorizes 1st breath test for COVID-19 infection

The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples. The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals, and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider. Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.” The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples. “InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.” Republished with the permission of the Associated Press.
GOP blocks Senate COVID bill, demands votes on immigration

Republicans blocked a Democratic attempt Tuesday to begin Senate debate on a $10 billion COVID-19 compromise, pressing to entangle the bipartisan package with an election-year showdown over immigration restrictions that poses a politically uncomfortable fight for Democrats. A day after Democratic and GOP bargainers reached an agreement on providing the money for treatments, vaccines, and testing, a Democratic move to push the measure past a procedural hurdle failed 52-47. All 50 Republicans opposed the move, leaving Democrats 13 votes short of the 60 votes they had needed to prevail. Hours earlier, Republicans said they’d withhold crucial support for the measure unless Democrats agreed to votes on an amendment preventing President Joe Biden from lifting Trump-era curbs on migrants entering the U.S. With Biden polling poorly on his handling of immigration and Democrats divided on the issue, Republicans see a focus on migrants as a fertile line of attack. “I think there will have to be” an amendment preserving the immigration restrictions “in order to move the bill,” bolstering federal pandemic efforts, Senate Minority Leader Mitch McConnell, R-Ky., told reporters. “I don’t think there are probably 10 Republican votes at the moment for a process that doesn’t include” a vote on language retaining the immigration barriers, said No. 2 Senate GOP leader John Thune of South Dakota. At least 10 GOP votes will be needed in the 50-50 Senate for the measure to reach the 60 votes it must have for approval. Biden and Senate Majority Leader Chuck Schumer, D-N.Y., want Congress to approve the pandemic bill before lawmakers leave in days for a two-week recess. Tuesday’s vote suggested that could be hard. ”This is a potentially devastating vote for every single American who was worried about the possibility of a new variant rearing its nasty head within a few months,” Schumer said after the vote. The new omicron variant, BA.2, is expected to spark a fresh increase in U.S. COVID-19 cases. Around 980,000 Americans and over 6 million people worldwide have died from the disease. The $10 billion pandemic package is far less than the $22.5 billion Biden initially sought. It also lacks $5 billion Biden wanted to battle the pandemic overseas — money that fell victim to disagreements over GOP demands that the measure be entirely paid for with budget savings. At least half the bill would be used for research and to produce therapeutics to treat COVID-19. Money would also be used to buy vaccines and tests and to research new variants. The measure is paid for by pulling back unspent funds provided earlier for protecting aviation manufacturing jobs, assisting entertainment venues shuttered by the pandemic, and other programs. Administration officials have said the government has run out of money to finance COVID-19 testing and treatments for people without insurance, and is running low on money for boosters, free monoclonal antibody treatments, and care for people with immune system weaknesses. At the 2020 height of the pandemic, President Donald Trump imposed immigration curbs letting authorities immediately expel asylum seekers and migrants for public health reasons. The ban is set to expire May 23, triggering what, by all accounts, will be a massive increase in the number of people trying to cross the Mexican border into the U.S. That confronts Democrats with messy choices ahead of fall elections when they’re expected to struggle to retain their hair-breadth majorities in the House and Senate. Many of the party’s lawmakers and their liberal supporters want the U.S. to open its doors to more immigrants. But moderates and some Democrats confronting tight November reelections worry about lifting the restrictions and alienating centrist voters. Shortly before Tuesday’s vote, Senate Majority Leader Chuck Schumer, D-N.Y., showed no taste for exposing his party to a divisive immigration vote. “This is a bipartisan agreement that does a whole lot of important good for the American people. Vaccines, testing, therapeutics,” he said. “It should not be held hostage for an extraneous issue.” Jeff Zients, head of White House COVID-19 task force, expressed the same view about an immigration provision. “This should not be included on any funding bill,” he told reporters. “The decision should be made by the CDC. That’s where it has been, and that’s where it belongs.” But Rep. Bennie Thompson, D-Miss., chairman of the House Homeland Security Committee, said he would still support a Senate COVID-19 aid bill if it included the GOP effort to retain the Trump immigration restrictions. “Why wouldn’t I?” he said in a brief interview. The federal Centers for Disease Control and Prevention, which initiated the move two years ago, said earlier this month that it would lift the ban next month. The restrictions, known as Title 42, have been harder to justify as pandemic restrictions have eased. Trump administration officials cast the curbs as a way to keep COVID-19 from spreading further in the U.S. Democrats considered that an excuse for Trump, whose anti-immigrant rhetoric was a hallmark of his presidency, to keep migrants from entering the country. Sen. Catherine Cortez Masto, D-Nev., who faces a competitive reelection this fall, declined to say Tuesday whether she would support retaining the Trump-era ban, saying she wanted to see its language. But she said the Biden administration needs to do more. “I’ve been very clear with the administration. I need a plan; we need a plan,” she said in a brief interview. “There’s going to be a surge at the border. There should be a plan, and I’ve been calling for it all along.” Republished with the permission of the Associated Press.
Democratic, GOP Senate bargainers reach $10 billion COVID agreement

Senate bargainers reached an agreement Monday on a slimmed-down $10 billion package for countering COVID-19 with treatments, vaccines, and other steps, the top Democratic and Republican negotiators said, but the measure dropped all funding to help nations abroad combat the pandemic. The compromise drew quick support from President Joe Biden, who initially pushed for a $22.5 billion package. In a setback, he ended up settling for much less amid administration warnings that the government was running out of money to keep pace with the disease’s continued — though diminished — spread in the U.S. “Every dollar we requested is essential, and we will continue to work with Congress to get all of the funding we need,” said White House press secretary Jen Psaki. “But time is of the essence. We urge Congress to move promptly on this $10 billion package because it can begin to fund the most immediate needs.” Biden and Senate Majority Leader Chuck Schumer, D-N.Y., his party’s lead bargainer, also ended up agreeing to abandon Biden’s request to include $5 billion to help countries — especially poorer ones — where the disease is still running rampant. But the two sides could not agree on enough budget savings to pay for the larger amounts. Schumer said the pact would provide “the tools we need” to help the country recover from the economic and public health blows that COVID-19 has inflicted for the past two years. But he said while the $10 billion “is absolutely necessary, it is well short of what is truly needed to keep up safe” over time. He said members of both parties want to craft a second spending measure this spring that could include funds to battle COVID-19 and hunger overseas and more assistance for Ukraine as it continues battling the Russian invasion. The fate of such a measure is uncertain. Sen. Mitt Romney of Utah, the lead GOP bargainer, hailed the accord as one that would address “urgent COVID needs.” He also trumped the measure’s savings, which he said meant it “will not cost the American people a single additional dollar.” Romney also suggested an openness to considering future money. “While this agreement does not include funding for the U.S. global vaccination program, I am willing to explore a fiscally responsible solution to support global efforts in the weeks ahead,” he said. The agreement comes with party leaders hoping to move the legislation through Congress this week, before lawmakers leave for a two-week spring recess. It also comes with BA.2, the new omicron variant, expected to spark a fresh increase in U.S. cases. Around 980,000 Americans and over 6 million people worldwide have died from COVID-19. At least half the compromise would have to be used to research and produce therapeutics to treat the disease, according to fact sheets from Schumer and Romney. The money would also be used to buy vaccines and tests. At least $750 million would be used to research new COVID-19 variants and to expand vaccine production, the descriptions said. The deal is also a reduction from a $15 billion version that both parties’ leaders had negotiated last month. House Speaker Nancy Pelosi, D-Calif., abandoned that plan after Democratic lawmakers rejected proposed cuts in state pandemic aid to help pay for the package. Some people said the fate of the new agreement remained uncertain in the House, where Pelosi and liberal Democrats have expressed opposition to dropping the money for helping other countries. Rep. Pramila Jayapal, leader of the House Progressive Caucus, said it is “a big problem” to erase the global assistance from the package. “It’s really shortsighted to not spend money on making sure this virus is contained around the world,” Jayapal, a Washington state Democrat who worked in global public health for a decade, told reporters. The agreement will need to attract at least 10 GOP votes to move through the 50-50 Senate. The others said the needed Republican votes would be there. The measure is fully paid for by pulling back unspent funds from previous pandemic relief bills that have been enacted, bargainers have said. Romney’s fact sheet says those savings include $2.3 billion from a fund protecting aviation manufacturing jobs; $1.9 billion from money for helping entertainment venues shuttered by the pandemic; another $1.9 billion from a program that helps states extend credit to small businesses; and $1.6 billion from agriculture assistance programs. Republished with the permission of the Associated Press.

